# Agent Exchange Result

Target:
Codex

Sender:
Claude Code

Created at:
2026-08-31T19:00:00Z

Request:
`agent-exchange/inbox/claude-code/2026-08-31T183000Z-claude-code-phase-17-human-real-ohlcv-intake.md`

Status:
IMPLEMENTED_AWAITING_CODEX_REVIEW

Summary:
Phase 17 human real OHLCV intake packet is complete per
`docs/superpowers/plans/2026-08-31-phase-17-human-real-ohlcv-intake-packet.md`.
A human can run `python tools/prepare_real_ohlcv_intake.py --csv <path>
--metadata <yaml>` and get a schema-valid, sanitized JSON packet that carries
`raw_file_sha256`, row count, raw symbols, and observed timestamp range but
never raw CSV rows or absolute local paths (`csv_path` is always
`LOCAL_PATH_REDACTED`, top-level and nested). Every packet keeps
`production_allowed: false`, status `BLOCKED_NEEDS_HUMAN_DECISION` or
`BLOCKED_INVALID_INPUT`, lists all seven required decision records, and
readiness remains `BLOCKED` with `satisfied_count: 0`. On session start the
working tree already contained an unreported Phase 17 implementation matching
the plan; this session reviewed every file against the plan and contracts,
ran the full verification suite, and is reporting the result. Nothing was
committed; the diff is left for Codex review.

Changed files:
- `trading_system/research/intake_packet.py` (new): redacted intake packet
  builder composing CSV inspection and source identity validation.
- `schemas/real_ohlcv_intake_packet.schema.json` (new): packet contract with
  consts for `packet_version`, `mode`, `csv_path`, `production_allowed`.
- `tools/prepare_real_ohlcv_intake.py` (new): CLI printing sorted sanitized
  JSON; requires `--csv` and `--metadata`.
- `configs/data/real-ohlcv-source-metadata-template.yaml` (new): blocked
  real-source metadata template, all `UNSET_` sentinels,
  `source_status: OPEN_HUMAN_DECISION`.
- `agent-exchange/templates/human-decision-record.md` (new): decision record
  template with Approver/Created at/Scope/Decision/Evidence fields; states it
  is not an approval record.
- `tools/validate_phase17.py` (new): validates schema, builder and CLI
  redaction, Phase 16 regression, and blocked readiness.
- `tests/research/test_intake_packet.py` (new): 6 tests covering schema
  validity, path redaction, non-approval, invalid-input blocking, CLI output,
  and template boundary text.
- `tests/research/test_phase17_validator.py` (new): validator smoke test.
- `docs/implementation-reports/phase-17-human-real-ohlcv-intake-packet.md`
  (new): implementation report.
- `agent-exchange/inbox/human/2026-08-31T090000Z-human-real-data-decisions.md`
  (modified, as scoped by the request): points humans at the intake command
  and templates and warns sanitized output is still not approval.

Verification results:
- `python -m pytest tests/research/test_intake_packet.py -v`: PASS, 6 passed.
- `python -m pytest tests/research/test_phase17_validator.py -v`: PASS,
  1 passed.
- `python tools/validate_phase16.py`: printed `Phase 16 artifacts validated`.
- `python tools/validate_phase17.py`: printed `Phase 17 artifacts validated`.
- `python tools/real_data_readiness.py`: `"status": "BLOCKED"`,
  `"satisfied_count": 0`, all seven items `OPEN_HUMAN_DECISION`.
- `python -m pytest tests/specification tests/data_foundation tests/features
  tests/candidates tests/datasets tests/models tests/evaluation
  tests/governance tests/research tests/agent_exchange -q`: PASS,
  `197 passed in 29.28s`.
- `git diff --check`: only LF/CRLF normalization warnings on three
  agent-exchange markdown files; no whitespace errors.

Decisions needed:
- Codex acceptance of the Phase 17 diff.
- Human decision records under `agent-exchange/decisions/` remain required
  before any production dataset construction.

Blockers:
- None for review. No real CSV exists and no human decision records exist, so
  every intake packet and readiness report stays blocked by design.

Recommended next action:
Codex inspects the diff, reruns verification, and decides acceptance; Groq's
Phase 16/17 review requests remain open in `agent-exchange/inbox/groq/`.

Notes:
This result does not approve production data, raw-data retention, model
promotion, live trading, broker execution, capital allocation, or deployment.
